» Articles » PMID: 4008047

Immunoregulation in Experimental Murine Candidiasis: Specific Suppression Induced by Candida Albicans Cell Wall Glycoprotein

Overview
Journal Infect Immun
Date 1985 Jul 1
PMID 4008047
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Immune regulation in candidiasis is inferred from studies of both human and animal infection, with a suppressive role suggested for cell wall polysaccharide. To study the immunosuppressive potential of Candida albicans in a murine model, whole blastoconidia or purified cell wall components of C. albicans were tested for their effects on the development of acquired immune responses by superimposing a pretreatment regimen upon an established immunization protocol. CBA/J or BALB/cByJ mice were pretreated twice intravenously with 100 micrograms of mannan (MAN), 100 or 200 micrograms of glycoprotein (GP), or 5 X 10(7) heat-killed C. albicans blastoconidia, followed 1 week later by an immunization protocol of two cutaneous inoculations of viable C. albicans blastoconidia given 2 weeks apart. Delayed hypersensitivity (DTH) to GP or to a membrane-derived antigen, B-HEX, was tested 7 days after the second inoculation, and lymphocyte stimulation was tested with mitogens and Candida antigens after 12 days. To assess protection, mice were challenged intravenously with viable C. albicans blastoconidia 14 days after the second cutaneous inoculation and sacrificed 28 days later for quantitative culture of kidneys and brains. Sera were obtained for enzyme-linked immunosorbent assays at selected intervals. Pretreatment with GP resulted in specific in vivo suppression of DTH to GP but not to B-HEX antigen and specific in vitro suppression of lymphocyte stimulation to GP but not to other Candida antigens or mitogens. MAN and heat-killed C. albicans blastoconidia had no such effects. GP pretreatment also diminished the protective effect of immunization against challenge, demonstrable in the brain, while not altering significantly the production of antibody in response to infection. Contrary to clinical evidence, MAN was not immunosuppressive in this model, and in fact, the immunosuppressive potential of GP, which is composed largely of MAN, was found to be dependent upon the presence of its heat-labile protein moiety.

Citing Articles

Evaluation of trained immunity by β-1, 3 (d)-glucan on murine monocytes in vitro and duration of response in vivo.

Garcia-Valtanen P, Guzman-Genuino R, Williams D, Hayball J, Diener K Immunol Cell Biol. 2017; 95(7):601-610.

PMID: 28228641 PMC: 5550561. DOI: 10.1038/icb.2017.13.


Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.

Chandra J, McCormick T, Imamura Y, Mukherjee P, Ghannoum M Infect Immun. 2007; 75(5):2612-20.

PMID: 17339351 PMC: 1865760. DOI: 10.1128/IAI.01841-06.


Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan.

Wang Y, Li S, Moser S, Bost K, Domer J Infect Immun. 1998; 66(4):1384-91.

PMID: 9529057 PMC: 108064. DOI: 10.1128/IAI.66.4.1384-1391.1998.


Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Ashman R, Papadimitriou J Microbiol Rev. 1995; 59(4):646-72.

PMID: 8531890 PMC: 239393. DOI: 10.1128/mr.59.4.646-672.1995.


Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host.

Tavares D, Salvador A, Ferreira P, Arala-Chaves M Infect Immun. 1993; 61(5):1881-8.

PMID: 8478077 PMC: 280779. DOI: 10.1128/iai.61.5.1881-1888.1993.


References
1.
Restrepo-Moreno A, Schneidau Jr J . Nature of the skin-reactive principle in culture filtrates prepared from Paracoccidioides brasiliensis. J Bacteriol. 1967; 93(6):1741-8. PMC: 276685. DOI: 10.1128/jb.93.6.1741-1748.1967. View

2.
Korn E, Northcote D . Physical and chemical properties of polysaccharides and glycoproteins of the yeast-cell wall. Biochem J. 1960; 75:12-7. PMC: 1204321. DOI: 10.1042/bj0750012. View

3.
Kirkpatrick C, Rich R, Bennett J . Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971; 74(6):955-78. DOI: 10.7326/0003-4819-74-6-955. View

4.
Cutler J, Friedman L, MILNER K . Biological and chemical characterization of toxic substances from Candida albicans. Infect Immun. 1972; 6(4):616-27. PMC: 422583. DOI: 10.1128/iai.6.4.616-627.1972. View

5.
ALFORD R, Goodwin R . Variation in lymphocyte reactivity to histoplasmin during the course of chronic pulmonary histoplasmosis. Am Rev Respir Dis. 1973; 108(1):85-92. DOI: 10.1164/arrd.1973.108.1.85. View